CPA
LMAT icon

Compass Planning Associates’s LeMaitre Vascular LMAT Stock Holding History

Compass Planning Associates’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,776
Closed -$978K – 82
2025
Q2 		$978K Hold
11,776
– – 0.9% 14
2025
Q1 		$988K Buy
11,776
+5,623
+91% +$523K 1% 11
2024
Q4 		$567K Buy
+6,153
New +$592K 0.58% 19

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Compass Planning Associates's LMAT Position: Q3 2025 in Review

Compass Planning Associates sold out of LeMaitre Vascular (LMAT) in Q3 2025, closing a stake of 11,776 shares — an estimated $978K sold.

Compass Planning Associates first reported a position in LMAT in Q4 2024 and held it in 3 quarters. The position peaked at $988K in Q1 2025. 297 funds tracked by Wall St. Rank hold LMAT as of Q3 2025.

  • Compass Planning Associates reported no remaining LeMaitre Vascular position as of Q3 2025 after selling out during the quarter.
  • Compass Planning Associates sold 11,776 LeMaitre Vascular shares in Q3 2025, an estimated $978K.
  • Compass Planning Associates first reported a position in LeMaitre Vascular in Q4 2024 and held it in 3 quarters.
  • Compass Planning Associates's LeMaitre Vascular position peaked at $988K in Q1 2025.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2025.

Based on Compass Planning Associates's 13F filing for Q3 2025, filed 22 Oct 2025.